M. Panzer

Impact of preoperative anemia, iron-deficiency and inflammation on survival after colorectal surgery—A retrospective cohort study

H. Tilg, H. Zoller, V. Petzer, 2022, PloS one.

Response‐guided long‐term treatment of chronic hepatitis D patients with bulevirtide—results of a “real world” study

M. Trauner, P. Ferenci, H. Holzmann, 2022, Alimentary pharmacology & therapeutics.

Synonymous mutation in adenosine triphosphatase copper‐transporting beta causes enhanced exon skipping in Wilson disease

H. Tilg, S. Kiechl, T. Todorov, 2022, Hepatology communications.

MRI‐Based Iron Phenotyping and Patient Selection for Next‐Generation Sequencing of Non–Homeostatic Iron Regulator Hemochromatosis Genes

H. Tilg, C. Kremser, A. Franke, 2021, Hepatology.

Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppression

M. Trauner, J. Camp, H. Zoller, 2023, JHEP reports : innovation in hepatology.

Reduced iron export associated with hepcidin resistance can explain the iron overload spectrum in ferroportin disease

H. Tilg, C. Decristoforo, G. Weiss, 2020, Liver international : official journal of the International Association for the Study of the Liver.

Neurodegeneration in Hepatic and Neurologic Wilson’s Disease

H. Tilg, C. Scherfler, B. Henninger, 2020, Hepatology.

Penetrance, cancer incidence and survival in HFE haemochromatosis—A population‐based cohort study

C. Gieger, C. Lamina, B. Schaefer, 2024, Liver international : official journal of the International Association for the Study of the Liver.